Jeremie Calais, MD, MSC

Dr. Calais is a nuclear medicine physician specialized in cancer imaging and theranostics. He has established a clinical Theranostics research program that combines academic investigator-initiated and industry sponsored studies using molcular targeted radionuclide imaging and therapy. The clinical research program focuses on translatable radiolabeled theranostic pairs that can be used and applied for diagnosis and therapy of cancer. The clinical research program involves close collaboration with clinical faculty across many departments at UCLA (Urology, Radiation Oncology, Radiology, Medical Oncology, Oncologic Surgery) but also with multiple national and international collaborators. His goal is to improve the outcome of patients with cancer through theranostic approaches and the application of knowledge gained from preclinical models and clinical studies.

• PubMed publications
   

• nytimes.com/2020/12/16/health/prostate-cancer-scan.html
• sanfrancisco.cbslocal.com/2021/02/25/the-game-changer-new-test-helps-doctors-find-hidden-prostate-cancer/
• newsroom.ucla.edu/releases/fda-approves-imaging-technique-for-prostate-cancer
• connect.uclahealth.org/2021/02/17/imaging-technique-investigated-at-ucla-health-a-major-advance-for-patients-with-prostate-cancer/
• newsroom.ucla.edu/dept/faculty/grant-expands-new-imaging-techniques-that-target-tumor-environment
• newsroom.ucla.edu/dept/faculty/jeremie-calais-young-investigator-award-prostate-cancer

• uclahealth.org/urology/iuo/calais-lab
• uclahealth.org/psma
• pharmacology.ucla.edu/people/jeremie-calais-m-d-msc/